AllSight
Companies · ATTO · Biological Products, (No Diagnostic Substances)
Attovia Therapeutics, Inc. (ATTO)
Attovia Therapeutics, Inc. (ATTO) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Sep 2, 2026In line
Attovia confirms ATTO-1310 proof of concept, but Q2 adds few surprises
Related companies in Biological Products, (No Diagnostic Substances)
About AllSight · Editorial standards & method · Contact